{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:31:14Z","timestamp":1794893474845,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Supplementing wildtype copies of functionally defective genes with adeno-associated virus (AAV) is a strategy being explored clinically for various retinal dystrophies. However, the low cargo limit of this vector allows its use in only a fraction of patients with mutations in relatively small pathogenic genes. To overcome this issue, we developed a single AAV platform that allows local replacement of a mutated sequence with its wildtype counterpart, based on combined CRISPR-Cas9 and micro-homology-mediated end-joining (MMEJ). In blind mice, the mutation replacement rescued approximately 10% of photoreceptors, resulting in an improvement in light sensitivity and an increase in visual acuity. These effects were comparable to restoration mediated by gene supplementation, which targets a greater number of photoreceptors. This strategy may be applied for the treatment of inherited disorders caused by mutations in larger genes, for which conventional gene supplementation therapy is not currently feasible.<\/jats:p>","DOI":"10.1038\/s41467-019-14181-3","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T11:03:06Z","timestamp":1579863786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-4421","authenticated-orcid":false,"given":"Koji M.","family":"Nishiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuki","family":"Miya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"issue":"1","key":"14181_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/bmb\/ldy005","volume":"126","author":"Neruban Kumaran","year":"2018","unstructured":"Kumaran N., Michaelides M., Smith A. J., Ali R. R., Bainbridge J. W. Retinal gene therapy. Br. Med. Bull. 126, 13\u201325 (2018).","journal-title":"British Medical Bulletin"},{"key":"14181_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80\u201386 (2010).","journal-title":"Mol. Ther."},{"issue":"10","key":"14181_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/jmedgenet-2018-105691","volume":"56","author":"Yoshito Koyanagi","year":"2019","unstructured":"Koyanagi Y., et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J. Med. Genet. 56, 662\u2013670 (2019).","journal-title":"Journal of Medical Genetics"},{"key":"14181_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder, M. L. et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med. 25, 229 (2019).","journal-title":"Nat. Med."},{"key":"14181_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","volume":"125","author":"YT Tsai","year":"2018","unstructured":"Tsai, Y. T. et al. Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa. Ophthalmology 125, 1421\u20131430 (2018).","journal-title":"Ophthalmology"},{"key":"14181_CR6","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Invest 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Invest"},{"key":"14181_CR7","doi-asserted-by":"publisher","first-page":"eaar3952","DOI":"10.1126\/sciadv.aar3952","volume":"3","author":"T Gaj","year":"2017","unstructured":"Gaj, T. et al. In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci. Adv. 3, eaar3952 (2017).","journal-title":"Sci. Adv."},{"key":"14181_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/crispr.2017.0009","volume":"1","author":"P Li","year":"2018","unstructured":"Li, P. et al. Allele-specific CRISPR-Cas9 genome editing of the single-base P23H mutation for rhodopsin-associated dominant retinitis pigmentosa. CRISPR J. 1, 55\u201364 (2018).","journal-title":"CRISPR J."},{"key":"14181_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K. et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540, 144\u2013149 (2016).","journal-title":"Nature"},{"key":"14181_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.3471","volume":"34","author":"H Yin","year":"2016","unstructured":"Yin, H. et al. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat. Biotechnol. 34, 328 (2016).","journal-title":"Nat. Biotechnol."},{"key":"14181_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551 (2014).","journal-title":"Nat. Biotechnol."},{"key":"14181_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat. Biotechnol. 34, 334 (2016).","journal-title":"Nat. Biotechnol."},{"key":"14181_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ebiom.2017.05.015","volume":"20","author":"X Yao","year":"2017","unstructured":"Yao, X. et al. CRISPR\/Cas9\u2013Mediated precise targeted integration in vivo using a double cut donor with short homology arms. EBioMedicine 20, 19\u201326 (2017).","journal-title":"EBioMedicine"},{"key":"14181_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6560","volume":"5","author":"S Nakade","year":"2014","unstructured":"Nakade, S. et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR\/Cas9. Nat. Commun. 5, 5560 (2014).","journal-title":"Nat. Commun."},{"key":"14181_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.preteyeres.2013.06.001","volume":"36","author":"TD Lamb","year":"2013","unstructured":"Lamb, T. D. Evolution of phototransduction, vertebrate photoreceptors and retina. Prog. Retin Eye Res. 36, 52\u2013119 (2013).","journal-title":"Prog. Retin Eye Res."},{"key":"14181_CR16","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.ymthe.2018.07.012","volume":"26","author":"KM Nishiguchi","year":"2018","unstructured":"Nishiguchi, K. M. et al. Retained plasticity and substantial recovery of rod-mediated visual acuity at the visual cortex in blind adult mice with retinal dystrophy. Mol. Ther. 26, 2397\u20132406 (2018).","journal-title":"Mol. Ther."},{"key":"14181_CR17","doi-asserted-by":"publisher","first-page":"e15063","DOI":"10.1371\/journal.pone.0015063","volume":"5","author":"AE Allen","year":"2010","unstructured":"Allen, A. E., Cameron, M. A., Brown, T. M., Vugler, A. A. & Lucas, R. J. Visual responses in mice lacking critical components of all known retinal phototransduction cascades. PLoS One 5, e15063 (2010).","journal-title":"PLoS One"},{"key":"14181_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.exer.2009.09.010","volume":"90","author":"M Miyamoto","year":"2010","unstructured":"Miyamoto, M. et al. A nonsense mutation in Gnat1, encoding the alpha subunit of rod transducin, in spontaneous mouse models of retinal dysfunction. Exp. Eye Res 90, 63\u201369 (2010).","journal-title":"Exp. Eye Res"},{"key":"14181_CR19","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1523\/JNEUROSCI.18-21-08936.1998","volume":"18","author":"C-J Jeon","year":"1998","unstructured":"Jeon, C.-J., Strettoi, E. & Masland, R. H. The major cell populations of the mouse retina. J. Neurosci. 18, 8936\u20138946 (1998).","journal-title":"J. Neurosci."},{"key":"14181_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7006","volume":"6","author":"KM Nishiguchi","year":"2015","unstructured":"Nishiguchi, K. M. et al. Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179. Nat. Commun. 6, 6006 (2015).","journal-title":"Nat. Commun."},{"key":"14181_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00424-006-0194-y","volume":"454","author":"Y Fu","year":"2007","unstructured":"Fu, Y. & Yau, K.-W. Phototransduction in mouse rods and cones. Pfl\u00fcgers Arch.-Eur. J. Physiol. 454, 805\u2013819 (2007).","journal-title":"Pfl\u00fcgers Arch.-Eur. J. Physiol."},{"key":"14181_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/bjophthalmol-2015-306939","volume":"100","author":"M Carrigan","year":"2016","unstructured":"Carrigan, M. et al. A novel homozygous truncating GNAT1 mutation implicated in retinal degeneration. Br. J. Ophthalmol. 100, 495\u2013500 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"14181_CR23","doi-asserted-by":"publisher","first-page":"19581","DOI":"10.1073\/pnas.0907720106","volume":"106","author":"B Chang","year":"2009","unstructured":"Chang, B. et al. A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene. Proc. Natl Acad. Sci. USA 106, 19581\u201319586 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"14181_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep18141","volume":"5","author":"K Fujita","year":"2015","unstructured":"Fujita, K. et al. In vivo cellular imaging of various stress\/response pathways using AAV following axonal injury in mice. Sci. Rep. 5, 18141 (2015).","journal-title":"Sci. Rep."},{"key":"14181_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1076\/ceyr.26.1.25.14249","volume":"26","author":"AF Wiechmann","year":"2003","unstructured":"Wiechmann, A. F. & Howard, E. W. Functional analysis of the human recoverin gene promoter. Curr. Eye Res. 26, 25\u201332 (2003).","journal-title":"Curr. Eye Res."},{"key":"14181_CR26","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1167\/iovs.07-0257","volume":"48","author":"SC Khani","year":"2007","unstructured":"Khani, S. C. et al. AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest Ophthalmol. Vis. Sci. 48, 3954\u20133961 (2007).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"14181_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omtm.2017.04.003","volume":"5","author":"K Fujita","year":"2017","unstructured":"Fujita, K., Nishiguchi, K. M., Shiga, Y. & Nakazawa, T. Spatially and temporally regulated NRF2 gene therapy using Mcp-1 promoter in retinal ganglion cell injury. Mol. Ther. Methods Clin. Dev. 5, 130\u2013141 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"14181_CR28","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281 (2013).","journal-title":"Nat. Protoc."},{"key":"14181_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1167\/iovs.07-1008","volume":"49","author":"KM Nishiguchi","year":"2008","unstructured":"Nishiguchi, K. M., Kaneko, H., Nakamura, M., Kachi, S. & Terasaki, H. Identification of photoreceptor precursors in the pars plana during ocular development and after retinal injury. Invest Ophthalmol. Vis. Sci. 49, 422\u2013428 (2008).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"14181_CR30","doi-asserted-by":"publisher","first-page":"e0156927","DOI":"10.1371\/journal.pone.0156927","volume":"11","author":"Y Tomiyama","year":"2016","unstructured":"Tomiyama, Y. et al. Measurement of electroretinograms and visually evoked potentials in awake moving mice. PLoS One 11, e0156927 (2016).","journal-title":"PLoS One"},{"key":"14181_CR31","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/mt.2010.149","volume":"18","author":"S Michalakis","year":"2010","unstructured":"Michalakis, S. et al. Restoration of cone vision in the CNGA3\u2212\/\u2212 mouse model of congenital complete lack of cone photoreceptor function. Mol. Ther. 18, 2057\u20132063 (2010).","journal-title":"Mol. Ther."},{"key":"14181_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34413-8","volume":"8","author":"N Tokashiki","year":"2018","unstructured":"Tokashiki, N. et al. Reliable detection of low visual acuity in mice with pattern visually evoked potentials. Sci. Rep. 8, 15948 (2018).","journal-title":"Sci. Rep."},{"key":"14181_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1017\/S0952523805225166","volume":"22","author":"RM Douglas","year":"2005","unstructured":"Douglas, R. M. et al. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Vis. Neurosci. 22, 677\u2013684 (2005).","journal-title":"Vis. Neurosci."},{"key":"14181_CR34","doi-asserted-by":"publisher","first-page":"16139","DOI":"10.1073\/pnas.1308243110","volume":"110","author":"KM Nishiguchi","year":"2013","unstructured":"Nishiguchi, K. M. et al. Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. Proc. Natl Acad. Sci. USA 110, 16139\u201316144 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14181-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:25:43Z","timestamp":1670261143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14181-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14181"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-14181-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.M.N., K.F. and T.N. are listed as inventors in a patent application related to this work. The other authors declare no competing interests. The Departments of Advanced Ophthalmic Medicine and Ophthalmic Imaging and Information Analytics are endowed departments, supported by an unrestricted grant from Senju Pharmaceutical Co. (Osaka, Japan) and Topcon Co. Ltd. (Tokyo, Japan), respectively. These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"482"}}